Wayne Axman, DPM
Foot Surgery · Astoria, NYNPI 1922043033
Payments from drug & device makers
What this record shows
This record is dominated by other: $8,908 of the $14,022 with a category attached, or 63.5%. Integra Lifesciences Corporation accounts for 71.3% of it on its own, with 43 other manufacturers making up the rest. Reporting peaked in 2024 at $10,069 and has fallen 89.9% since, to $1,017 in 2025. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $62.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$10K
- Stryker$646
- Smith+Nephew$622
- Xeris Pharmaceuticals, Inc.$268
- Treace Medical Concepts, Inc.$209
- Advanced Oxygen Therapy Inc.$196
- plus $2K from 38 others
What the payments were for
- Food & beverage$5,11336%
- Other$8,90864%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$8,575
- ACell$245
- FLOWTRIEVER CATHETER, S$195
- CT THROMBECTOMY SYSTEM KIT$195
- Lapiplasty System$168
- HOFFMANN$147
- T2$147
- SONICANCHOR$147
- Topical oxygen chamber for extremities$122
- ALLOWRAP$115
- BIO4$115
- ANCHORAGE$115
- Novosorb BTM$107
- SALVATION$102
- PROPHECY$102
- VALOR$102
How this compares
$14,022 in reported general payments places this provider in the 95th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 199 | $34,839 |
| Clobetasol Propionate | 45 | $20,438 |
| Fluocinonide | 161 | $17,404 |
| Caspofungin Acetate | 27 | $7,628 |
| Diclofenac Sodium ErDiclofenac Sodium | 95 | $7,547 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 17 | $4,812 |
| Clotrimazole | 86 | $4,258 |
| Diclofenac Sodium | 12 | $1,249 |
| Ammonium Lactate | 26 | $380 |
| Mupirocin | 16 | $114 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Astoria
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.